Published in Vaccine Weekly, August 30th, 2006
Study 1: A study from Germany has reported on the therapeutic efficacy of antigen-specific vaccination and toll-like receptor (TLR) stimulation against established transplanted and autochthonous melanoma in mice.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly